SPI
17.920,70
PKT
-37,96
PKT
-0,21
%
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 17.08.12 | Straumann neutral | Nomura | |
| 17.08.12 | Swatch (I) buy | Nomura | |
| 17.08.12 | Julius Bär neutral | Citigroup Corp. | |
| 17.08.12 | Zurich Insurance buy | Nomura | |
| 17.08.12 | Holcim neutral | Credit Suisse Group | |
| 17.08.12 | Zurich Insurance buy | Goldman Sachs Group Inc. | |
| 17.08.12 | Tecan (N) buy | UBS AG | |
| 17.08.12 | Tecan (N) hold | Vontobel Research | |
| 17.08.12 | Basilea Pharmaceutica hold | Vontobel Research | |
| 17.08.12 | Holcim buy | UBS AG | |
| 17.08.12 | Schweiter hold | Vontobel Research | |
| 17.08.12 | Orell Fuessli hold | Vontobel Research | |
| 17.08.12 | Dätwyler hold | Vontobel Research | |
| 17.08.12 | Holcim hold | Vontobel Research | |
| 17.08.12 | COLTENE hold | Vontobel Research | |
| 17.08.12 | Swiss Life buy | Vontobel Research | |
| 17.08.12 | PSP Swiss Property hold | Vontobel Research | |
| 17.08.12 | Holcim buy | Société Générale Group S.A. (SG) | |
| 17.08.12 | Zurich Insurance halten | Independent Research GmbH | |
| 16.08.12 | Zurich Insurance hold | Commerzbank Corp. & Markets | |
| 16.08.12 | Swisscom buy | Citigroup Corp. | |
| 16.08.12 | Holcim outperform | Exane-BNP Paribas SA | |
| 16.08.12 | Zurich Insurance buy | Sarasin Research | |
| 16.08.12 | Kardex hold | Vontobel Research | |
| 16.08.12 | Mobimo buy | Sarasin Research | |
| 16.08.12 | Basilea Pharmaceutica buy | Sarasin Research | |
| 16.08.12 | Forbo International buy | Vontobel Research | |
| 16.08.12 | Zurich Insurance buy | ING | |
| 16.08.12 | Mobimo hold | Vontobel Research | |
| 16.08.12 | Basilea Pharmaceutica hold | Vontobel Research | |
| 16.08.12 | Swiss Re neutral | Sarasin Research | |
| 16.08.12 | Orior hold | Vontobel Research | |
| 16.08.12 | Holcim hold | Société Générale Group S.A. (SG) | |
| 16.08.12 | Tecan (N) hold | Vontobel Research | |
| 16.08.12 | Zurich Insurance buy | Vontobel Research | |
| 16.08.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 16.08.12 | UBS halten | Hamburger Sparkasse AG (Haspa) | |
| 15.08.12 | Holcim neutral | Sarasin Research | |
| 15.08.12 | Forbo International buy | Sarasin Research | |
| 15.08.12 | Novartis buy | Nomura |